Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Mehmel Robert FPresident and COO |  GFFGRIFFON CORPOpen-market sale · 10b5-1 plan | SELL | $4,999 52 sh | Jun 30, 2026 |
| 4 | Hug JoshuaDirector |  RELYRemitly Global, Inc.Open-market sale · 10b5-1 plan | SELL | $379K 16.8K sh | Jun 30, 2026 traded Jun 30, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $188K 12.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 4 | Hug JoshuaDirector | RELYRemitly Global, Inc. Open-market sale · 10b5-1 plan | SELL | $386K 16.8K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 4 | Talasaz AmirAliDirector, Co-Chief Executive Officer | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | — 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 3 | Puri SumeetChief Accounting Officer |  EOSEEos Energy Enterprises, Inc.Option exercise · 10b5-1 plan | M | — 17.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Silberman Michael WChief Legal Officer | EOSEEos Energy Enterprises, Inc. Option exercise · 10b5-1 plan | M | — 30.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 3 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOption exercise · 10b5-1 plan | M | — 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | $467K 111.8K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $211K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Talasaz AmirAliDirector, Co-Chief Executive Officer | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | $598K 143.0K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 2 | Daunt JohnEVP, Chief Commercial Officer | LQDTLIQUIDITY SERVICES INC Option exercise · 10b5-1 plan | M | $71K 3,287 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $100K 24.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 1 | Daunt JohnEVP, Chief Commercial Officer | LQDTLIQUIDITY SERVICES INC Open-market sale · 10b5-1 plan | SELL | $1,528 39 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health |  TDOCTeladoc Health, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 2,500 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Morris Matthew ShawnDirector |  PRVAPrivia Health Group, Inc.Option exercise · 10b5-1 plan | M | — 63.2K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Feider StephenChief Financial Officer |  BBNXBeta Bionics, Inc.Option exercise · 10b5-1 plan | M | $25K 4,896 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | BBNXBeta Bionics, Inc. Option exercise · 10b5-1 plan | M | $25K 4,982 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO |  CDNACareDx, Inc.Option exercise · 10b5-1 plan | M | — 39.9K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | — 8,897 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Talasaz AmirAliDirector, Co-Chief Executive Officer | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | — 143.0K sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Feider StephenChief Financial Officer | BBNXBeta Bionics, Inc. Option exercise · 10b5-1 plan | M | — 4,896 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | — 5,962 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | — 1,336 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | — 1,001 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Mountcastle DavidEVP & Chief Financial Officer | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | $34K 17.2K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 1,837 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Kroeker NathanCCO and Interim CFO | EOSEEos Energy Enterprises, Inc. Option exercise · 10b5-1 plan | M | — 70.6K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | CDNACareDx, Inc. Option exercise · 10b5-1 plan | M | — 100 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $22K 1,837 sh | Jun 30, 2026 traded Jun 29, 2026 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $134K 11.0K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Morris Matthew ShawnDirector | PRVAPrivia Health Group, Inc. Option exercise · 10b5-1 plan | M | — 88.1K sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Hanna John Walter JRDirector, President and CEO | CDNACareDx, Inc. Option exercise · 10b5-1 plan | M | $820 100 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 0 | Feider StephenChief Financial Officer | BBNXBeta Bionics, Inc. Option exercise · 10b5-1 plan | M | — 4,982 sh | Jun 30, 2026 traded Jun 26, 2026 |
| 45 | Leatherberry Antoinette ReneeDirector |  DRCTDirect Digital Holdings, Inc.Open-market sale | SELL | $198 67 sh | Jun 29, 2026 traded Jun 9, 2026 |
| 41 | Locke MistelleDirector | DRCTDirect Digital Holdings, Inc. Open-market sale | SELL | $72.75 25 sh | Jun 29, 2026 traded Jun 12, 2026 |
| 41 | Locke MistelleDirector | DRCTDirect Digital Holdings, Inc. Open-market sale | SELL | $225 76 sh | Jun 29, 2026 traded Jun 9, 2026 |
| 40 | Locke MistelleDirector | DRCTDirect Digital Holdings, Inc. Open-market sale | SELL | $202 31 sh | Jun 29, 2026 traded Jan 16, 2026 |